PITTSBURGH (AP) – Mylan Inc. said it is now selling a generic version of Sanofi’s enlarged-prostate drug Uroxatral.
The approval allows Mylan to sell 10-milligram tablets of the drug. The company said Uroxatral, or alfuzosin, had $241 million in revenue over the year ended June 30. The drug was first approved in June 2003.
Date: August 12, 2011
Source: Associated Press
Filed Under: Drug Discovery